Craneware plc Director/PDMR Shareholding and Total Voting Rights (8831X)
23 Dicembre 2019 - 4:15PM
UK Regulatory
TIDMCRW
RNS Number : 8831X
Craneware plc
23 December 2019
Craneware plc
("Craneware", "the Group" or the "Company")
Director's Exercise of Options and Total Voting Rights
23 December 2019 - Craneware (AIM: CRW.L), the market leader in
Value Cycle solutions for the US healthcare market, announces that
Keith Neilson, CEO of the Company, has exercised options over
10,332 ordinary shares of 1p each ("Ordinary Shares") at an
exercise price of 335 pence per Ordinary Share.
Following the exercise of these options, Mr Neilson holds
3,397,506 Ordinary Shares in the capital of the Company,
representing 12.7 per cent. of the Company's issued share capital.
Following completion and settlement of all taxation matters
relating to this exercise, Mr Neilson intends to transfer these
shares to the Neilson Family Foundation, a charity trust set up for
the future benefit of medical research and Young People's
charities.
Following this exercise and the exercise of options by another
employee, the Company's issued share capital will comprise
26,826,539 Ordinary Shares. The Company does not hold any Ordinary
Shares in treasury. This figure of 26,826,539 may be used by
shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or
a change to their interest in, the Company, under the Financial
Conduct Authority's Disclosure and Transparency Rules.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Keith Neilson
------------------------------------------------ --------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------------------
a) Position/Status: Chief Executive Officer
------------------------------------------------ --------------------------------------------
b) Initial Notification/Amendment: Initial Notification
------------------------------------------------ --------------------------------------------
3 Details of the issuer, emission allowance market participation,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------------
a) Name: Craneware plc
------------------------------------------------ --------------------------------------------
b) LEI: 213800O2CTJ1YFXNXG05
------------------------------------------------ --------------------------------------------
4. Details of transaction(s); section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted.
----------------------------------------------------------------------------------------------
a) Description of Ordinary Shares
the financial ISIN GB00B2425G68
instrument:
Identification
code:
------------------------------------------------ --------------------------------------------
b) Nature of the Exercise of options over Ordinary Shares
transaction:
------------------------------------------------ --------------------------------------------
c) Price(s) and volume(s): GBP3.35 10,332
------------------------------------------------ ------------------------ ------------------
Aggregated price(s)
d) and volume(s): GBP3.35 10,332
------------------------------------------------ ------------------------ ------------------
e) Date of the Transaction: 20 December 2019
------------------------------------------------ --------------------------------------------
f) Place of the Transaction: Outside of a trading venue
------------------------------------------------ --------------------------------------------
For further information, please contact:
Craneware plc Peel Hunt Investec Bank Alma
(NOMAD & Joint (Joint Broker) (Financial PR)
Broker)
+44 (0)131 550 +44 (0)20 7418 +44 (0)20 7597 +44 (0)203 405
3100 8900 5970 0205
Keith Neilson, Dan Webster Patrick Robb Caroline Forde
CEO
Craig Preston, George Sellar Sebastian Lawrence Hilary Buchanan
CFO
Guy Pengelley Henry Reast Helena Bogle
About Craneware
Craneware enables healthcare providers to improve margins and
enhance patient outcomes so they can continue to provide quality
outcomes for all.
Craneware is the leader in automated Value Cycle solutions that
help US Healthcare provider organisations discover, convert and
optimise assets to achieve best clinical outcomes and financial
performance. Founded in 1999, Craneware is headquartered in
Edinburgh, Scotland with offices in Atlanta and Pittsburgh
employing over 350 staff. Craneware's market-driven, SaaS solutions
normalise disparate data sets, bringing in up-to-date regulatory
and financial compliance data to deliver value at the points where
clinical and operational data transform into financial
transactions, creating actionable insights that enable informed
tactical and strategic decisions. To learn more, visit
craneware.com and thevaluecycle.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHFEDFIDFUSEFE
(END) Dow Jones Newswires
December 23, 2019 10:15 ET (15:15 GMT)
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Lug 2023 a Lug 2024
